// App-Quantinova.ai

4015 : Phase III trial of s-1 plus oxaliplatin (SOX) vs s-1 plus cisplatin (SP) combination chemotherapy for first-line treatment of advanced gastric cancer (AGC): SOPP study.

Researchers

Presenter

  • Min-Hee Ryu

Principal Investigators

  • Young Iee Park

  • Ik-Joo Chung

  • Keun-Wook Lee

  • Ho-Suk Oh

  • Kyung Hee Lee

  • Hye Sook Han

  • Bong-Gun Seo

  • Jae-Cheol Jo

  • Hyo Rak Lee

  • Sook Ryun Park

  • Yoon-Koo Kang

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastroesophageal junction (GEJ) adenocarcinoma

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Oxaliplatin

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Non Inferiority

  • Multicenteric

Phase

  • III

Study Id's

  • NCT01671449

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved